These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 11165756)

  • 21. ERbeta in breast cancer--onlooker, passive player, or active protector?
    Fox EM; Davis RJ; Shupnik MA
    Steroids; 2008 Oct; 73(11):1039-51. PubMed ID: 18501937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.
    Litwiniuk MM; Roznowski K; Filas V; Godlewski DD; Stawicka M; Kaleta R; Breborowicz J
    BMC Cancer; 2008 Apr; 8():100. PubMed ID: 18405391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of estrogen-responsive genes involved in breast cancer metastases to the bone.
    Wang J; Jarrett J; Huang CC; Satcher RL; Levenson AS
    Clin Exp Metastasis; 2007; 24(6):411-22. PubMed ID: 17593529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.
    Skliris GP; Leygue E; Curtis-Snell L; Watson PH; Murphy LC
    Br J Cancer; 2006 Sep; 95(5):616-26. PubMed ID: 16880783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
    Yamashita H; Nishio M; Kobayashi S; Ando Y; Sugiura H; Zhang Z; Hamaguchi M; Mita K; Fujii Y; Iwase H
    Breast Cancer Res; 2005; 7(5):R753-64. PubMed ID: 16168121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers.
    O'Neill PA; Davies MP; Shaaban AM; Innes H; Torevell A; Sibson DR; Foster CS
    Br J Cancer; 2004 Nov; 91(9):1694-702. PubMed ID: 15477865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression.
    Bardin A; Boulle N; Lazennec G; Vignon F; Pujol P
    Endocr Relat Cancer; 2004 Sep; 11(3):537-51. PubMed ID: 15369453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.
    Nakopoulou L; Lazaris AC; Panayotopoulou EG; Giannopoulou I; Givalos N; Markaki S; Keramopoulos A
    J Clin Pathol; 2004 May; 57(5):523-8. PubMed ID: 15113861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsies.
    Saunders PT; Millar MR; Williams K; Macpherson S; Bayne C; O'Sullivan C; Anderson TJ; Groome NP; Miller WR
    Br J Cancer; 2002 Jan; 86(2):250-6. PubMed ID: 11870515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ER beta inhibits proliferation and invasion of breast cancer cells.
    Lazennec G; Bresson D; Lucas A; Chauveau C; Vignon F
    Endocrinology; 2001 Sep; 142(9):4120-30. PubMed ID: 11517191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ki-67 is a prognostic marker for hormone receptor positive tumors.
    Pérez-López ME; García-Gómez J; Alves MT; Paradela A; García-Mata J; García-Caballero T
    Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of wild-type estrogen receptor beta protein in human breast cancer: specific correlation with HER2/neu overexpression.
    Umekita Y; Souda M; Ohi Y; Sagara Y; Rai Y; Takahama T; Yoshida H
    Pathol Int; 2006 Aug; 56(8):423-7. PubMed ID: 16872435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
    Omoto Y; Inoue S; Ogawa S; Toyama T; Yamashita H; Muramatsu M; Kobayashi S; Iwase H
    Cancer Lett; 2001 Feb; 163(2):207-12. PubMed ID: 11165756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.
    Järvinen TA; Pelto-Huikko M; Holli K; Isola J
    Am J Pathol; 2000 Jan; 156(1):29-35. PubMed ID: 10623650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.
    Demir H; Turna H; Can G; Ilvan S
    J BUON; 2010; 15(4):774-82. PubMed ID: 21229645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between hormone receptor status and age, and its prognostic implications in breast cancer patients in Bahrain.
    AlZaman AS; Mughal SA; AlZaman YS; AlZaman ES
    Saudi Med J; 2016 Jan; 37(1):37-42. PubMed ID: 26739972
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.